It has been reported that cisplatin resistance of human ovarian cancer is related to activation of PI3K/Akt and ERK1/2 signaling pathways [15]–[16], we then determined the potential involvement of these two pathways in cisplatin and doxycycline effects on ovarian cancer cell proliferation. The gene discussed is MAPK3; the disease is ovarian carcinoma.